|
gptkbp:instanceOf
|
gptkb:nucleoside
|
|
gptkbp:actsOn
|
gptkb:adenosine_receptors
|
|
gptkbp:administeredBy
|
intravenous injection
|
|
gptkbp:ATCCode
|
C01EB10
|
|
gptkbp:CASNumber
|
58-61-7
|
|
gptkbp:chemicalFormula
|
C10H13N5O4
|
|
gptkbp:contraindication
|
gptkb:sick_sinus_syndrome
gptkb:second-_or_third-degree_AV_block
bronchospastic lung disease
|
|
gptkbp:discoveredBy
|
gptkb:Albrecht_Kossel
|
|
gptkbp:discoveredIn
|
1891
|
|
gptkbp:enemyOf
|
gptkb:theophylline
caffeine
theobromine
|
|
gptkbp:foundIn
|
all living cells
|
|
gptkbp:hasComponent
|
adenine
ribose
|
|
gptkbp:hasInChIKey
|
OIRDTQYFTABQOQ-KQYNXXCUSA-N
|
|
gptkbp:hasRole
|
gptkb:immunosuppressant
gptkb:vasodilator
gptkb:neurotransmitter
gptkb:antiarrhythmic_agent
|
|
gptkbp:hasSMILES
|
C1=NC2=C(N1)N=CN2C3C(C(C(O3)CO)O)O
|
|
gptkbp:hasUNII
|
K72T3FS567
|
|
gptkbp:IUPACName
|
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
|
|
gptkbp:KEGGID
|
D00024
|
|
gptkbp:meltingPoint
|
234–236 °C
|
|
gptkbp:metabolism
|
gptkb:ATP
gptkb:AMP
gptkb:ADP
gptkb:adenosine_deaminase
|
|
gptkbp:molecularWeight
|
267.24 g/mol
|
|
gptkbp:predecessor
|
gptkb:adenosine_triphosphate
gptkb:adenosine_diphosphate
adenosine monophosphate
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL418471
16335
60961
DB00640
|
|
gptkbp:role
|
gptkb:neurotransmitter
signal transduction
energy transfer
vasodilation
regulates sleep
|
|
gptkbp:sideEffect
|
shortness of breath
hypotension
flushing
chest discomfort
|
|
gptkbp:solubility
|
83 mg/mL
|
|
gptkbp:usedAs
|
cardiac antiarrhythmic agent
|
|
gptkbp:usedIn
|
gptkb:medicine
gptkb:pharmacy
biochemistry
|
|
gptkbp:bfsParent
|
gptkb:adenosine_receptor
gptkb:Coenzyme_A
gptkb:supraventricular_tachycardia
gptkb:CHEBI:17754
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
adenosine
|